Serum uric acid plays a protective role for bone loss in peri- and postmenopausal women: A longitudinal study

Bone

Volumn 52, Issue 1, 2013, Pages 400-406

  Makovey, Joanna ^a   Macara, Monique ^a   Chen, Jian Sheng ^a   Hayward, Christopher S ^b,c   March, Lyn ^a   Seibel, Markus J ^d   Sambrook, Philip N ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d ANZAC RESEARCH INSTITUTE   (Australia)

Author keywords

Body composition; Bone loss; Bone mineral density; Fat mass; Uric acid

Indexed keywords

CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; URIC ACID;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BODY WEIGHT; BONE DENSITY; BONE TURNOVER; CLIMACTERIUM; CROSS-SECTIONAL STUDY; DATA ANALYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOREARM; HUMAN; LEAN BODY WEIGHT; LONGITUDINAL STUDY; LUMBAR SPINE; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; OSTEOLYSIS; POSTMENOPAUSE; REGRESSION ANALYSIS; URIC ACID BLOOD LEVEL;

ABSORPTIOMETRY, PHOTON; AGED; BONE DENSITY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; OSTEOPOROSIS; PERIMENOPAUSE; POSTMENOPAUSE; URIC ACID;

EID: 84868678259     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.10.025     Document Type: Article

References (54)

1. Edwards N.L. The role of hyperuricemia and gout in kidney and cardiovascular disease. Cleve Clin J Med 2008, 75:S13-S16.
2. Mandell B.F. Clinical manifestations of hyperuricemia and gout. Cleve Clin J Med 2008, 75:S5-S8.
3. Masseoud D., Rott K., Liu-Bryan R., Agudelo C. Overview of hyperuricaemia and gout. Curr Pharm Des 2005, 11:4117-4124.
4. Rossi S.E. Australian medicines handbook 2012 2012, Australian Medicines Handbook Pty Ltd., Adelaide.
5. Glantzounis G.K., Tsimoyiannis E.C., Kappas A.M., Galaris D.A. Uric acid and oxidative stress. Curr Pharm Des 2005, 11:4145-4151.
6. Dalbeth N., Merriman T. Crystal ball gazing: new therapeutic targets for hyperuricaemia and gout. Rheumatology 2009, 48:222-226.
7. Lippi G., Montagnana M., Franchini M., Favaloro E.J., Targher G. The paradoxical relationship between serum uric acid and cardiovascular disease. Clin Chim Acta 2008, 392:1-7.
8. Sanchez-Rodriguez M., Ruiz-Ramos M., Correa-Munoz E., Mendoza-Nunez V. Oxidative stress as a risk factor for osteoporosis in elderly Mexicans as characterized by antioxidant enzymes. BMC Musculoskelet Disord 2007, 8:124.
9. Sugiura M., Nakamura M., Ogawa K., Ikoma Y., Ando F., Yano M. Bone mineral density in post-menopausal female subjects is associated with serum antioxidant carotenoids. Osteoporos Int 2008, 19:211-219.
10. Sahni S., Hannan M.T., Blumberg J., Cupples L.A., Kiel D.P., Tucker K.L. Inverse association of carotenoid intakes with 4-y change in bone mineral density in elderly men and women: the Framingham Osteoporosis Study. Am J Clin Nutr 2009, 89:416-424.
11. Sendur O.F., Turan Y., Tastaban E., Serter M. Antioxidant status in patients with osteoporosis: a controlled study. Joint Bone Spine 2009, 76:514-518.
12. Lee H.J., Park H.T., Cho G.J., Yi K.W., Ahn K.H., Shin J.H., et al. Relationship between uric acid and metabolic syndrome according to menopausal status. Gynecol Endocrinol 2010, 1-6.
13. Ishizaka N., Ishizaka Y., Toda E.I., Nagai R., Yamakado M. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol 2005, 25:1038-1044.
14. Puig J.G., Martinez M.A. Hyperuricemia, gout and the metabolic syndrome. Curr Opin Rheumatol 2008, 20:187-191.
15. Oda E., Kawai R., Sukumaran V., Watanabe K. Uric acid is positively associated with metabolic syndrome but negatively associated with diabetes in Japanese men. Intern Med 2009, 48:1785-1791.
16. Dehghan A., van Hoek M., Sijbrands E.J.G., Hofman A., Witteman J.C.M. High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care 2008, 31:361-362.
17. Kramer C.K., Von Muhlen D., Jassal S.K., Barrett-Connor E. Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose. Diabetes Care 2009, 32:1272-1273.
18. Lee J., Sparrow D., Vokonas P.S., Landsberg L., Weiss S.T. Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome. The Normative Aging Study. Am J Epidemiol 1995, 142:288-294.
19. Iribarren C., Folsom A.R., Eckfeldt J.H., McGovern P.G., Nieto F.J. Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC Study. Atherosclerosis Risk in Communities. Ann Epidemiol 1996, 6:331-340.
20. Bonora E., Targher G., Zenere M.B., Saggiani F., Cacciatori V., Tosi F., et al. Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int J Obes Relat Metab Disord 1996, 20:975-980.
21. Russo C., Olivieri O., Girelli D., Guarini P., Corrocher R. Relationships between serum uric acid and lipids in healthy subjects. Prev Med 1996, 25:611-616.
22. Alderman M.H. Serum uric acid as a cardiovascular risk factor for heart disease. Curr Hypertens Rep 2001, 3:184-189.
23. Ahmed N., Anwar W., Waqas H. Obesity, hyperlipidemia, and hyperuraecemia in young and old hypertensive patients. J Ayub Med Coll Abbottabad 2009, 21:53-56.
24. Mazzali M., Kanbay M., Segal M., Shafiu M., Jalal D., Feig D., et al. Uric acid and hypertension: cause or effect?. Curr Rheumatol Rep 2010, 12:108-117.
25. Kirchengast S., Peterson B., Hauser G., Knogler W. Body composition characteristics are associated with the bone density of the proximal femur end in middle- and old-aged women and men. Maturitas 2001, 39:133-145.
26. Pongchaiyakul C., Nguyen T., Kosulwat V., Rojroongwasinkul N., Charoenkiatkul S., Eisman J., et al. Contribution of lean tissue mass to the urban-rural difference in bone mineral density. Osteoporos Int 2005, 16:1761-1768.
27. Dytfeld J., Ignaszak-Szczepaniak M., Gowin E., Michalak M., Horst-Sikorska W. Influence of lean and fat mass on bone mineral density (BMD) in postmenopausal women with osteoporosis. Arch Gerontol Geriatr 2011, 53:e237-e242.
28. Gjesdal C.G., Halse J.I., Eide G.E., Brun J.G., Tell G.S. Impact of lean mass and fat mass on bone mineral density: the Hordaland Health Study. Maturitas 2008, 59:191-200.
29. Makovey J., Naganathan V., Sambrook P. Gender differences in relationships between body composition components, their distribution and bone mineral density: a cross-sectional opposite sex twin study. Osteoporos Int 2005, 16:1495-1505.
30. Bogl L.H., Latvala A., Kaprio J., Sovijarvi O., Rissanen A., Pietilainen K.H. An investigation into the relationship between soft tissue body composition and bone mineral density in a young adult twin sample. J Bone Miner Res 2011, 26:79-87.
31. Nabipour I., Sambrook P.N., Blyth F.M., Janu M.R., Waite L.M., Naganathan V., et al. Serum uric acid is associated with bone health in older men: a cross-sectional population-based study. J Bone Miner Res 2011, 26:955-964.
32. Sarna S., Kaprio J., Sistonen P., Koskenvuo M. Diagnosis of twin zygosity by mailed questionnaire. Hum Hered 1978, 28:241-254.
33. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16:31-41.
34. Gault M.H., Longerich L.L., Harnett J.D., Wesolowski C. Predicting glomerular function from adjusted serum creatinine. Nephron 1992, 62:249-256.
35. Makovey J., Chen J.S., Hayward C., Williams F.M., Sambrook P.N. Association between serum cholesterol and bone mineral density. Bone 2009, 44:208-213.
36. Christian J.C., Yu P.L., Slemenda C.W., Johnston C.C. Heritability of bone mass: a longitudinal study in aging male twins. Am J Hum Genet 1989, 44:429-433.
37. Bainbridge K.E., Sowers M.F., Crutchfield M., Lin X., Jannausch M., Harlow S.D. Natural history of bone loss over 6 years among premenopausal and early postmenopausal women. Am J Epidemiol 2002, 156:410-417.
38. Ho S.C., Chan S.G., Yip Y.B., Chan C.S., Woo J.L., Sham A. Change in bone mineral density and its determinants in pre- and perimenopausal Chinese women: the Hong Kong Perimenopausal Women Osteoporosis Study. Osteoporos Int 2008, 19:1785-1796.
39. Kaptoge S., Reid D.M., Scheidt-Nave C., Poor G., Pols H.A., Khaw K.T., et al. Geographic and other determinants of BMD change in European men and women at the hip and spine. a population-based study from the Network in Europe for Male Osteoporosis (NEMO). Bone 2007, 40:662-673.
40. Hannan M.T., Tucker K.L., Dawson-Hughes B., Cupples L.A., Felson D.T., Kiel D.P. Effect of dietary protein on bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res 2000, 15:2504-2512.
41. Sirola J., Salovaara K., Rikkonen T., Karkkainen M., Tuppurainen M., Jurvelin J.S., et al. Bone health-related factors and the use of bisphosphonates in community setting-15-year follow-up study. Osteoporos Int 2011, 22:255-264.
42. Loenen H.M.J.A., Eshuis H., Löwik M.R.H., Schouten E.G., Hulshof K.F.A.M., Odink J., et al. Serum uric acid correlates in elderly men and women with special reference to body composition and dietary intake (Dutch nutrition surveillance system). J Clin Epidemiol 1990, 43:1297-1303.
43. Abrahamsen B., Stilgren L.S., Hermann A.P., Tofteng C.L., Barenholdt O., Vestergaard P., et al. Discordance between changes in bone mineral density measured at different skeletal sites in perimenopausal women-implications for assessment of bone loss and response to therapy: the Danish Osteoporosis Prevention Study. J Bone Miner Res 2001, 16:1212-1219.
44. Dennison E., Eastell R., Fall C.H., Kellingray S., Wood P.J., Cooper C. Determinants of bone loss in elderly men and women: a prospective population-based study. Osteoporos Int 1999, 10:384-391.
45. Orozco P. Atherogenic lipid profile and elevated lipoprotein (a) are associated with lower bone mineral density in early postmenopausal overweight women. Eur J Epidemiol 2004, 19:1105-1112.
46. Tanko L.B., Bagger Y.Z., Nielsen S.B., Christiansen C. Does serum cholesterol contribute to vertebral bone loss in postmenopausal women?. Bone 2003, 32:8-14.
47. Hangartner T.N. A study of the long-term precision of dual-energy X-ray absorptiometry bone densitometers and implications for the validity of the least-significant-change calculation. Osteoporos Int 2007, 18:513-523.
48. Blake G.M., Herd R.J., Patel R., Fogelman I. The effect of weight change on total body dual-energy X-ray absorptiometry: results from a clinical trial. Osteoporos Int 2000, 11:832-839.
49. Patel R., Blake G.M., Rymer J., Fogelman I. Long-term precision of DXA scanning assessed over seven years in forty postmenopausal women. Osteoporos Int 2000, 11:68-75.
50. Rajamanohara R., Robinson J., Rymer J., Patel R., Fogelman I., Blake G.M. The effect of weight and weight change on the long-term precision of spine and hip DXA measurements. Osteoporos Int 2011, 22:1503-1512.
51. Nguyen T.V., Center J.R., Eisman J.A. Femoral neck bone loss predicts fracture risk independent of baseline BMD. J Bone Miner Res 2005, 20:1195-1201.
52. McLean R.R., Jacques P.F., Selhub J., Fredman L., Tucker K.L., Samelson E.J., et al. Plasma B vitamins, homocysteine, and their relation with bone loss and hip fracture in elderly men and women. J Clin Endocrinol Metab 2008, 93:2206-2212.
53. Lippi G., Montagnana M., Luca S.G., Targher G., Cesare G.G. Epidemiological association between uric acid concentration in plasma, lipoprotein(a), and the traditional lipid profile. Clin Cardiol 2010, 33:E76-E80.
54. Lippi G., Montagnana M., Franchini M., Guidi G.C., Targher G. Uric acid concentration in patient with acute coronary syndrome. Intern Emerg Med 2008, 3:409-411.